Testing & Timing

Suboxone and drug testing.

Buprenorphine is not detected on every standard drug screen. Which panels include it, how long it stays detectable, and what to expect — by specimen type.

All topics

Medically reviewed by N Elias, MD, board-certified in addiction medicine·Last reviewed May 2026

Looking for treatment? Same-day visits usually available. No insurance required.

Call or text Book online

Does Suboxone show up on a drug test?

Suboxone (buprenorphine) does not appear on most standard drug tests. It requires a specific buprenorphine panel to be detected. In clinical settings, these panels are often used, but most workplace tests do not include it.

Standard panels

Most standard drug tests do not detect buprenorphine.

The most common workplace drug screen — the SAMHSA-5, also called a 5-panel test — tests for amphetamines, cocaine, marijuana, opiates, and phencyclidine (PCP). Buprenorphine is not included.

A 10-panel test adds barbiturates, benzodiazepines, methaqualone, methadone, and propoxyphene to the standard five. Buprenorphine is not included in most standard 10-panel tests unless it is specifically added to the panel.

Extended panels exist that specifically test for buprenorphine. These are increasingly used in clinical settings — particularly in substance use treatment programs — and may be ordered by some employers or courts. When in doubt, ask what specific substances the test screens for.

Detection windows

How long buprenorphine is detectable depends on the specimen.

Detection windows are approximate and vary based on dose, frequency of use, metabolism, body composition, and kidney function. The figures below represent typical ranges based on published pharmacokinetic data.

Urine

The most common specimen type. Buprenorphine and its metabolite norbuprenorphine are typically detectable in urine for approximately 3–7 days after the last dose at standard doses. At higher doses or after extended use, detection may extend to approximately 10–14 days.

Saliva

Oral fluid testing detects buprenorphine for approximately 1–3 days after the last dose. Saliva testing is less common for buprenorphine, though it may be used in some point-of-care or forensic settings.

Blood

Blood testing provides a shorter detection window — typically about 24–72 hours for buprenorphine. Blood tests are less common outside of clinical or forensic contexts.

Hair

Hair follicle testing can detect buprenorphine for up to 90 days, consistent with the standard hair testing window. Hair tests are uncommon for buprenorphine but are used in some clinical and legal settings.

In clinical treatment

Drug testing in buprenorphine treatment.

Drug testing in medication treatment programs serves a different purpose than employment screening. Clinical testing is used to monitor treatment progress, assess medication adherence, and identify co-occurring substance use that may affect safety — not to create grounds for discharge.

A positive result for buprenorphine on a clinical test may support adherence, though interpretation depends on the type of test and the clinical context. A negative result when a patient is prescribed buprenorphine may prompt a clinical conversation about adherence or test interpretation, not automatic discharge.

At MyStreetHealth, drug testing results are treated as clinical information — used to inform care decisions, not to punish patients.

Sources

Where this information comes from.

Federal guidance

SAMHSA Mandatory Guidelines for Federal Workplace Drug Testing

Defines standard panels and cutoff levels for federally mandated workplace drug testing.

Clinical reference

Donroe JH et al. — Buprenorphine and Norbuprenorphine Urine Levels (CCJM 2022)

How to interpret quantitative buprenorphine and norbuprenorphine urine levels in clinical practice, including detection windows and clinical significance.

Lab reference

Mayo Clinic Laboratories — Buprenorphine and Norbuprenorphine, Urine

Detection methodology, cutoff levels, and clinical notes on buprenorphine urine testing from Mayo Clinic Laboratories.

Clinical guideline

ASAM National Practice Guideline (2020)

Guidance on drug testing in medication treatment programs — purpose, frequency, and interpretation.

Federal guidance

SAMHSA: Buprenorphine

Overview of buprenorphine treatment, including monitoring and urine drug testing considerations.

Related

← All Learn topics  ·  How long does Suboxone last  ·  Opioid detection times  ·  Fentanyl detection  ·  Hydrocodone detection  ·  Oxycodone detection

MyStreetHealth serves

Virginia  ·  Maryland  ·  Washington DC  ·  West Virginia  ·  Ohio

Common questions

Frequently asked

Will Suboxone show up on a standard drug test?

Standard 5-panel tests do not include buprenorphine. A separate buprenorphine-specific immunoassay is required to detect it.

Do employers typically test for Suboxone?

Most standard workplace drug panels do not test for buprenorphine. Some regulated industries (DOT, federal contractors) may use expanded panels. Check with whoever is ordering the test.

How long after stopping will buprenorphine still show on a test?

Generally several days after the last dose, though this varies by dose, duration of use, and individual metabolism. Longer-term use at higher doses may extend the detection window.

Also on this site

Questions about treatment?

Same-day visits usually available.

(888) 835-9995 · Call or text Book online LegitScript verified
Home
Patient login Book online